Clinical Trials Browser

Pancreatic Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Pancreatic Neoplasms

Colorectal Neoplasms

Adenocarcinoma Of Esophagus

Colorectal Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Adenocarcinoma, Neoplasms

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Biphenotypic, Acute

Pancreatic Neoplasms

Colorectal Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Adenocarcinoma

Rectal Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

First-line Treatment of Metastatic Pancreatic Cancer

Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Esophageal Squamous Cell Carcinoma

Stomach Neoplasms

Pancreatic Neoplasms

Carcinoma, Hepatocellular

Colorectal Neoplasms

Colorectal Neoplasms

First-line Treatment of Advanced Pancreatic Cancer

Carcinoma, Hepatocellular

Adenocarcinoma, Stomach Neoplasms

Carcinoma, Hepatocellular

Clinical Trials

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

NEO-RT

OrigAMI-2

OrigAMI-3

KANDLELIT-012

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Beacon-BTC

LAP100

MOUNTAINEER-03

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

HARMONi-GI3

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

LUCERNA

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

MK-3475-C66

TRIBE-C

AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer

FOBEAR

CAPRI-3 GOIM

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

AIO-KRK-0418

Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer

AtezoTRIBE2

LIBImAb

The Sagittarius Trial

OSCAR

PANThEON

The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy

NEEDS

PREVENT

PREOPANC-3

HAIC

IMPROVE-2

Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer

HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer

FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial

Perioperative FLOT vs Adjuvant XELOX for CA Stomach

Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation